1. Home
  2. GMM vs NOTV Comparison

GMM vs NOTV Comparison

Compare GMM & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

N/A

Current Price

$1.33

Market Cap

39.6M

Sector

N/A

ML Signal

N/A

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.83

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMM
NOTV
Founded
2017
1974
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.6M
29.9M
IPO Year
2023
1997

Fundamental Metrics

Financial Performance
Metric
GMM
NOTV
Price
$1.33
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
15.6K
1.6M
Earning Date
08-18-2025
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.79
N/A
Revenue
$48,171,048.00
$513,024,000.00
Revenue This Year
N/A
$6.26
Revenue Next Year
N/A
$45.49
P/E Ratio
$0.75
N/A
Revenue Growth
41.74
4.54
52 Week Low
$1.23
$0.66
52 Week High
$4.97
$6.48

Technical Indicators

Market Signals
Indicator
GMM
NOTV
Relative Strength Index (RSI) 29.00 39.32
Support Level $1.25 $0.79
Resistance Level $1.59 $0.95
Average True Range (ATR) 0.10 0.08
MACD -0.01 0.01
Stochastic Oscillator 23.08 36.76

Price Performance

Historical Comparison
GMM
NOTV

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: